Winton Group’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-3,900
| Closed | -$353K | – | 1548 |
|
|
2026
Q1 | $353K | Buy |
+3,900
| New | +$358K | 0.01% | 818 |
|
|
2025
Q2 | – | Sell |
-30,307
| Closed | -$3.43M | – | 1028 |
|
|
2025
Q1 | $3.43M | Buy |
+30,307
| New | +$3.24M | 0.21% | 116 |
|
|
2023
Q4 | – | Sell |
-34,278
| Closed | -$3.85M | – | 873 |
|
|
2023
Q3 | $3.85M | Buy |
+34,278
| New | +$4.35M | 0.32% | 51 |
|
|
2023
Q2 | – | Sell |
-16,952
| Closed | -$2.19M | – | 1160 |
|
|
2023
Q1 | $2.19M | Buy |
16,952
+14,431
| +572% | +$1.81M | 0.13% | 193 |
|
|
2022
Q4 | $321K | Buy |
+2,521
| New | +$293K | 0.02% | 772 |
|
|
2021
Q4 | – | Sell |
-10,312
| Closed | -$1.47M | – | 1451 |
|
|
2021
Q3 | $1.47M | Buy |
+10,312
| New | +$1.52M | 0.08% | 319 |
|
|
2021
Q2 | – | Sell |
-3,041
| Closed | -$473K | – | 1530 |
|
|
2021
Q1 | $473K | Buy |
3,041
+1,317
| +76% | +$204K | 0.03% | 922 |
|
|
2020
Q4 | $258K | Sell |
1,724
-9,324
| -84% | -$1.32M | 0.02% | 1103 |
|
|
2020
Q3 | $1.46M | Sell |
11,048
-6,867
| -38% | -$897K | 0.05% | 658 |
|
|
2020
Q2 | $2.08M | Sell |
17,915
-3,902
| -18% | -$450K | 0.05% | 633 |
|
|
2020
Q1 | $2.14M | Buy |
21,817
+14,819
| +212% | +$1.94M | 0.06% | 553 |
|
|
2019
Q4 | $1.02M | Sell |
6,998
-83,361
| -92% | -$11.5M | 0.01% | 1063 |
|
|
2019
Q3 | $12M | Buy |
+90,359
| New | +$11.7M | 0.14% | 188 |
|
|
2018
Q4 | – | Sell |
-2,045
| Closed | -$261K | – | 1064 |
|
|
2018
Q3 | $261K | Sell |
2,045
-137
| -6% | -$16.3K | 0.01% | 874 |
|
|
2018
Q2 | $236K | Sell |
2,182
-29,408
| -93% | -$3.2M | 0.01% | 915 |
|
|
2018
Q1 | $3.34M | Sell |
31,590
-985
| -3% | -$114K | 0.09% | 263 |
|
|
2017
Q4 | $3.82M | Buy |
32,575
+29,320
| +901% | +$3.32M | 0.11% | 307 |
|
|
2017
Q3 | $370K | Buy |
+3,255
| New | +$376K | 0.01% | 587 |
|
|
2015
Q4 | – | Sell |
-570,951
| Closed | -$52.1M | – | 371 |
|
|
2015
Q3 | $52.1M | Buy |
570,951
+373,314
| +189% | +$37.4M | 0.41% | 81 |
|
|
2015
Q2 | $21M | Buy |
197,637
+105,382
| +114% | +$11.7M | 0.19% | 189 |
|
|
2015
Q1 | $10.5M | Sell |
92,255
-52,895
| -36% | -$6.04M | 0.08% | 292 |
|
|
2014
Q4 | $16M | Sell |
145,150
-204,760
| -59% | -$21.6M | 0.2% | 191 |
|
|
2014
Q3 | $34.2M | Sell |
349,910
-203,049
| -37% | -$20M | 0.24% | 172 |
|
|
2014
Q2 | $55.8M | Buy |
+552,959
| New | +$54M | 0.38% | 81 |
|
Other funds holding ZBH
Winton Group's ZBH Position: Q2 2026 in Review
Winton Group sold out of Zimmer Biomet (ZBH) in Q2 2026, closing a stake of 3,900 shares — an estimated $353K sold.
Winton Group first reported a position in ZBH in Q2 2014 and held it in 24 quarters. The position peaked at $55.8M in Q2 2014. 906 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.
- Winton Group reported no remaining Zimmer Biomet position as of Q2 2026 after selling out during the quarter.
- Winton Group sold 3,900 Zimmer Biomet shares in Q2 2026, an estimated $353K.
- Winton Group first reported a position in Zimmer Biomet in Q2 2014 and held it in 24 quarters.
- Winton Group's Zimmer Biomet position peaked at $55.8M in Q2 2014.
- 906 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.
Based on Winton Group's 13F filing for Q2 2026, filed 7 Aug 2026.